Literature DB >> 20736251

Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development.

Min Nie1, Qi Zhou, Jiangfeng Mao, Shuangyu Lu, Xueyan Wu.   

Abstract

Individuals with male karyotype (46,XY) affected by 5α-reductase type 2 deficiency, a rare autosomal recessive inherited disorder, can have an almost female phenotype or partially virilized external genitalia. Mutations in the steroid-5-α-reductase (SRD5A2) gene, leading to functional impairment of 5α-reductase type 2, are responsible for this disorder. Our present study analyzed SRD5A2 gene mutations in eight unrelated 46,XY Chinese patients with disorders of sex development. Direct sequencing of genomic DNA for SRD5A2 gene revealed the presence of one homozygous (p.Q6X) and seven compound heterozygous mutations (p.G203S/R227Q, p.L20P/R227Q, p.Q6X/p.A228V, p.C222Ffs232X/p.R246Q, p.W140X/F219Sfs278X, p.Q71X/L185Tfs192X and p.Q6X/p.N193S) in our patients. Among them, p.C222Ffs232X, p.A228V, p.Q71X, L185Tfs192X and p.W140X mutations have not been previously reported. These novel mutations may provide us new insights into the molecular mechanism of 5α-reductase type 2 deficiency. Seven out of eight patients had at least one variant in exon 4, and 8 of 12 (66.7%) mutations were located in exon 4. The expanded mutation database of the SRD5A2 gene should benefit patients in the diagnosis and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20736251     DOI: 10.1093/molehr/gaq072

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  8 in total

1.  Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.

Authors:  M Rahimi; M Ghanbari; Z Fazeli; M Rouzrokh; S Omrani; R Mirfakhraie; M D Omrani
Journal:  J Endocrinol Invest       Date:  2016-11-15       Impact factor: 4.256

2.  46,XY disorders of sex development: the use of NGS for prevalent variants.

Authors:  Qi-Gen Xie; Peng Luo; Kai Xia; Zuo-Qing Li; Zhe Xu; Cheng Su; Chun-Hua Deng
Journal:  Hum Genet       Date:  2022-06-21       Impact factor: 4.132

3.  Novel mutation of SRD5A2 gene in a patient with 5α-reductase 2 deficiency from India.

Authors:  Iram Shabir; Eunice Marumudi; Madan L Khurana; Rajesh Khadgawat
Journal:  BMJ Case Rep       Date:  2012-10-30

4.  Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study.

Authors:  Xiu Zhao; Yanning Song; Shaoke Chen; Xiumin Wang; Feihong Luo; Yu Yang; Linqi Chen; Ruimin Chen; Hui Chen; Zhe Su; Di Wu; Chunxiu Gong
Journal:  Front Pharmacol       Date:  2019-03-15       Impact factor: 5.810

5.  Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency.

Authors:  Tong Cheng; Hao Wang; Bing Han; Hui Zhu; Hai-Jun Yao; Shuang-Xia Zhao; Wen-Jiao Zhu; Hua-Ling Zhai; Fu-Guo Chen; Huai-Dong Song; Kai-Xiang Cheng; Yang Liu; Jie Qiao
Journal:  Asian J Androl       Date:  2019 Nov-Dec       Impact factor: 3.285

6.  Clinical characteristics and genotype-phenotype correlations of 130 Chinese children in a high-homogeneity single-center cohort with 5α-reductase 2 deficiency.

Authors:  Lijun Fan; Yanning Song; Michel Polak; Lele Li; Xiaoya Ren; Beibei Zhang; Di Wu; Chunxiu Gong
Journal:  Mol Genet Genomic Med       Date:  2020-07-26       Impact factor: 2.183

7.  Accuracy of Urinary Etiocholanolone/Androsterone Ratio as Alternative to Serum Testosterone/Dihydrotestosterone Ratio for Diagnosis of 5 Alpha-reductase Type 2 Deficiency Patients and Carriers in Indonesia.

Authors:  Nanis Sacharina Marzuki; Firman Pratama Idris; Hannie Kartapradja; Shirley Renata; Alida Harahap; Jose Rizal Latief Batubara
Journal:  Int J Endocrinol Metab       Date:  2021-04-18

8.  Characterising SRD5A2 Gene Variants in 37 Indonesian Patients with 5-Alpha-Reductase Type 2 Deficiency.

Authors:  Nanis S Marzuki; Firman P Idris; Hannie D Kartapradja; Alida R Harahap; Jose R L Batubara
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.